Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response
- 1 March 1998
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 48 (1) , 11-20
- https://doi.org/10.1023/a:1005973529921
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor statusBritish Journal of Cancer, 1993
- Tamoxifen alone is not adequate treatment for most elderly patients with operable breast cancerThe Breast, 1992
- Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysisCytometry, 1992
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.Journal of Clinical Oncology, 1986
- Relationship Between Estrogen Receptors and Cellular ProliferationPublished by Springer Nature ,1984
- Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.BMJ, 1982
- Estimates of lead time and length bias in a breast cancer screening programCancer, 1980
- Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancerPublished by Elsevier ,1980
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978